Playback speed
10 seconds
KEYNOTE-189: Clinical Implications in Patients with Low (1-49%) Tumor PD-L1 Expression
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
7 views
November 2, 2018
Dr. Jack West reviews clinical results in patients with advanced non-squamous NSCLC and low (1-49%) ...
read more ↘ tumor PD-L1 on the KEYNOTE-189 trial, providing thoughts on the clinical implications of these findings in the management of this patient subset.
↖ read less
read more ↘ tumor PD-L1 on the KEYNOTE-189 trial, providing thoughts on the clinical implications of these findings in the management of this patient subset.
↖ read less
Login to view comments.
Click here to Login
Lung